The present invention relates to a nematic liquid crystal composition that is useful as an electro-optical liquid crystal display material arid exhibits a positive value of dielectric anisotropy (Δε).
A liquid crystal display element is used for various measuring equipment, panels for an automobile, word processors, electronic notebooks, printers, computers, televisions, timepieces, advertisement display boards, and the like, as well as timepieces and electronic calculators. As a liquid crystal display mode, representative examples thereof include a Twisted Nematic (TN) mode, a Super Twisted Nematic (STN) mode, and a VA mode that is characterized in a vertical alignment or an In-Plane Switching (IPS) mode/Fringe Field Switching (FFS) mode that is characterized in a horizontal alignment, which uses a Thin Film Transistor (TFT). A liquid crystal composition used for this liquid crystal display element is required to be stable against external factors such as moisture, air, heat, and light; exhibit a liquid crystal phase in a wide temperature range as much as possible, which is around room temperature; and have low viscosity and low driving voltage. Furthermore, the liquid crystal composition is composed of several or tens of types of compounds, in order to obtain an optimal dielectric anisotropy (Δε) and/or an optimal value of refractive index anisotropy (Δn) or the like when applied to respective display elements.
In a vertical alignment mode display, a liquid crystal composition having negative Δε is used, and in a horizontal alignment mode display such as a TN mode, a STN mode or an IPS mode, a liquid crystal composition having positive Δε is used. In recent years, a driving mode has been reported, in which a liquid crystal composition having positive Δε is vertically aligned in the absence of applied voltage, and a horizontal electric field is applied similarly to an IPS mode/FFS mode. Since it is estimated that the liquid crystal display element using this driving mode will further grow later on as a small and medium-sized display such as a smart phone, necessity of the liquid crystal composition having positive Δε is further increased.
Meanwhile, in all of the driving modes, in the case where the liquid crystal display element is applied to a television, or the like, a high response speed is important and accordingly, in the liquid crystal composition for a display element, a response speed is required to be improved and a liquid crystal composition having a higher Δn and a lower viscosity, as compared with the current composition, is demanded. Also, from the viewpoint of adjusting Δn×d, which is a product of Δn and a cell gap (d), to a predetermined value, it is necessary to adjust Δn of the liquid crystal composition within an appropriate range depending on a cell gap. However, in a display such as a FFS mode, a liquid crystal composition having further higher Δn is required because of a reduction in the gap, and therefore, a high response speed is further demanded. Moreover, in particular, a wide operation temperature range is demanded for the use of a mobile phone. That is, the liquid crystal composition is required to exhibit a high refractive index anisotropy (Δn) and a high temperature for transition from a nematic phase to an isotropic liquid phase (Tni) while having a relatively low viscosity.
In the related art, as a constituent component of the liquid crystal composition, for example, compounds represented by General Formulas (A) to (C) are used in combination to achieve an increase of Δn (PTL 1 and PTL 2).
R represents an alkyl group or an alkenyl group.
However, the compound of General Formula (A) has a low Tni, which is lower and higher of 0° C., the compound of General Formula (B) has a relatively high Tni, which is lower and higher of 160° C., but insufficient compatibility, and the compound of General Formula (C) has high Δn, which is before and after 0.24, but deteriorated compatibility, and has a Tni of around 120° C. As a component configuring the liquid crystal composition having a wide nematic temperature range, the physical property values are not sufficient.
Patent Literature
[PTL 1] JP-T-2007-526931
[PTL 2] JP-A-2003-261873
An object of the present invention is to provide a liquid crystal composition which has high refractive index anisotropy (Δn) and sufficiently low viscosity (η), achieves a wide nematic phase temperature range by suppressing a decrease in temperature for transition from a nematic phase to an isotropic liquid phase (Tni), exhibits high compatibility, and has a high response speed and excellent reliability when the liquid crystal composition of the present invention is used in a liquid crystal display element.
The present inventors have reviewed a variety of fluorobenzene derivatives and found out that the problem can be solved by using specific compounds in combination, thereby completing the present invention.
The present invention provides a liquid crystal composition including at least one compound represented by General Formula (1), at least one compound represented by General Formula (2), and at least one compound represented by General Formula (LC1), and further provides a liquid crystal display element using the liquid crystal composition.
In the formula, R01 represents an alkyl group having 1 to 15 carbon atoms or an alkenyl group having 2 to 15 carbon atoms, and one —CH2— or two or more —CH2— in these groups may be substituted with —O—, —S—, —COO—, —OCO—, or —CO— as long as an oxygen atom is not directly adjacent to another oxygen atom, and at least one hydrogen atom present in these groups may be substituted with a fluorine atom;
R02 represents an alkenyl group having 2 to 15 carbon atoms, one —CH2— or two or more —CH2— present in the alkenyl group may be substituted with —O—, —S—, —COO—, —OCO—, or —CO— as long as an oxygen atom is not directly adjacent to another oxygen atom, and at least one hydrogen atom present in the alkenyl group may be substituted with a fluorine atom;
A1 is a group selected from the group consisting of (a) 1,4-cyclohexylene group in which one —CH2— or two or more —CH2— non-adjacent to each other present in this group may be substituted with —O— or —S—, (b) 1,4-phenylene group in which one —CH═ or two or more —CH═ non-adjacent to each other present in this group may be substituted with —N═ and at least one hydrogen atom present in this group may be substituted with a fluorine atom, and (c) naphthalene-2,6-diyl group in which one —CH═ or two or more —CH═ non-adjacent to each other present in this group may be substituted with —N═ and at least one hydrogen atom present in this group may be substituted with a fluorine atom;
Z1 represents —CH2O—, —OCH2—, —CF2O—, —OCF2—, —COO—, —OCO—, —CH2CH2—, —CF2CF2—, —CH═CH—, —CF═CF—, —C≡C—, or a single bond;
X1 represents a hydrogen atom, a fluorine atom, or a chlorine atom; and
m represents 1 to 4, in the case where m is 2 to 4 and plural A1's are present, the plural A1's may be the same as or different from each other, and in the case where m is 2 to 4 and plural Z1's are present, the plural Z1's may be the same as or different from each other.
In the formula, R21 represents an alkyl group having 1 to 15 carbon atoms or an alkenyl group having 2 to 15 carbon atoms, and one —CH2— or two or more —CH2— non-adjacent to each other present in these groups may be substituted with —O—, —S—, —COO—, —OCO—, or —CO—, and at least one hydrogen atom present in these groups may be substituted with a fluorine atom;
A21 is a group selected from the group consisting of (a) 1,4-cyclohexylene group in which one —CH2— or two or more —CH2— non-adjacent to each other present in this group may be substituted with —O— or —S—, (b) 1,4-phenylene group in which one —CH═ or two or more —CH═ non-adjacent to each other present in this group may be substituted with —N═ and at least one hydrogen atom present in this group may be substituted with a fluorine atom, and (c) naphthalene-2,6-diyl group in which one —CH═ or two or more —CH═ non-adjacent to each other present in this group may be substituted with —N═ and at least one hydrogen atom present in this group may be substituted with a fluorine atom; and
B21 is a compound represented by either of the following structures.
In the structures, X21, X22, X23, X24, and X25 each independently represents a hydrogen atom, a fluorine atom, or a chlorine atom and Y21 and Y22 each independently represents a halogen atom, a cyano group, a halogenated alkyl group having 1 to 5 carbon atoms, or a halogenated alkoxy group having 1 to 5 carbon atoms;
Z21 represents —CH2O—, —OCH2—, —CF2O—, —OCF2—, —OCO—, —OCO—, —CH2CH2—, —CF2CF2—, —CH═CH—, —CF═CF—, —C≡C—, or a single bond; and
m21 represents 1, 2, or 3, in the case where m21 is 2 or 3 and plural A21's are present, the plural A21's may be the same as or different from each other, and in the case where m21 is 2 or 3 and plural Z21's are present, the plural Z21's may be the same as or different from each other.
In the formula, R11 and R12 each independently represents an alkyl group having 1 to 15 carbon atoms, and one —CH2— or two or more —CH2— in the alkyl group may be substituted with —O—, —CH═CH—, —CO—, —OCO—, —COO—, —C≡C—, —CF2O—, or —OCF2— as long as an oxygen atom is not directly adjacent to another oxygen atom, and one or more hydrogen atoms in the alkyl group may be substituted with a halogen atom;
A11 to A13 each independently is a group selected from the group consisting of (a) 1,4-cyclohexylene group in which one —CH2— or two or more —CH2— non-adjacent to each other present in this group may be substituted with —O— or —S—, (b) 1,4-phenylene group in which one —CH═ or two or more —CH═ non-adjacent to each other present in this group may be substituted with —N═ and at least one hydrogen atom present in this group may be substituted with a fluorine atom, and (c) naphthalene-2,6-diyl group in which one —CH═ or two or more —CH═ non-adjacent to each other present in this group may be substituted with —N═ and at least one hydrogen atom present in this group may be substituted with a fluorine atom;
Z11 and Z12 each independently represents a single bond, —CH═CH—, —C≡C—, —CH2CH2—, —(CH2)4—, —OCH2—, —CH2O—, —OCF2—, or —CF2O—; and
m11 represents 0, 1, or 2, in the case where m11 is 2 and plural A11's are present, the plural A11's may be the same as or different from each other, and in the case where m11 is 2 and plural Z11's are present, the plural Z11's may be the same as or different from each other, with the proviso that the compound represented by General Formula (1) is excluded.
The liquid crystal composition of the present invention has high refractive index anisotropy (Δn), low viscosity (η), low rotational viscosity (γ1), and excellent crystallinity, and exhibits a stable liquid crystal phase in a wide temperature range. In addition, since the liquid crystal composition of the present invention is chemically stable with respect to heat, light, and water, and has satisfactory solubility, the phase at low temperature is satisfactorily stable. By using the liquid crystal composition of the present invention in a liquid crystal display element, it is possible to obtain a liquid crystal display element having a high response speed and high practical reliability.
The liquid crystal composition of the present invention includes at least one compound represented by General Formula (1), at least one compound represented by General Formula (2), and at least one compound represented by General Formula (LC1).
General Formula (1):
In order to decrease the viscosity, R01 is preferably an alkyl group having 1 to 8 carbon atoms or an alkenyl group having 2 to 8 carbon atoms, and particularly preferably an alkyl group having 1 to 5 carbon atoms or an alkenyl group having 2 to 5 carbon atoms. Also, R01 is preferably linear. In the case where R1 is an alkenyl group, R1 is preferably selected from the group represented by any one of Formula (R1) to Formula (R5). (A black point in each formula represents a point linking to a ring.) In the case where A1 which is linked to R1 is a trans-1,4-cyclohexylene group, R01 preferably represents an alkenyl group of the trans-1,4-cyclohexylene group, and further preferably represents Formula (R1), Formula (R2), or Formula (R4).
In order to decrease the viscosity, R 02 is preferably an alkenyl group having 2 to 8 carbon atoms, more preferably an alkenyl group having 2 to 6 carbon atoms, preferably an alkenyl group having 2 to 5 carbon atoms, and it is preferred that the group represented by —O—R 02 is selected from the groups represented by Formula (R6).
In the formula, R04 represents a hydrogen atom or an alkyl group having 1 to 3 carbon atoms, one —CH2— or two or more —CH2— non-adjacent to each other present in these groups may be substituted with —O—, —COO—, —OCO—, or —CO—, at least one hydrogen atom present in these groups may be substituted with a fluorine atom, and a black point in each formula represents a point linking to a ring.
The following groups where R04 is a hydrogen atom or a methyl group are more preferable.
In order to decrease the viscosity, A1 each is independently preferably represents a trans-1,4-cyclohexylene group, an unsubstituted naphthalene-2,6-diyl group, or an unsubstituted 1,4-phenylene group, and more preferably a trans-1,4-cyclohexylene group. In order to improve the miscibility with other liquid crystal components, the following groups:
are preferable as A1.
In addition, in order to increase the Δn, A1 each is independently preferably a 1,4-phenylene group or a naphthalene-2,6-diyl group. In all of the ring structures in the compound, it is preferred that the abundance ratio of the 1,4-phenylene group and naphthalene-2,6-diyl group is relatively high, and it is more preferred that the abundance ratio of the 1,4-phenylene group is relatively high. In the case of putting importance on Δn, the abundance ratio of the 1,4-phenylene group and naphthalene-2,6-diyl group is preferably increased to fall within the preferable range, but is adjusted depending on a balance of viscosity and miscibility with other liquid crystal components. Specifically, in the case where m represents 1, A1 is preferably a trans-1,4-cyclohexylene group, a 1,4-phenylene group, or a naphthalene-2,6-diyl group, and in order to further increase the ratio, A1 preferably represents a 1,4-phenylene group or a naphthalene-2,6-diyl group, and more preferably represents a 1,4-phenylene group. In the case where m represents 2, at least one of A1's is preferably a 1,4-phenylene group or a naphthalene-2,6-diyl group, and in order to further increase the ratio, A1 each is independently preferably a 1,4-phenylene group or a naphthalene-2,6-diyl group, and more preferably a 1,4-phenylene group. In the case where m represents 3 or 4, at least one of A1's is preferably a 1,4-phenylene group or a naphthalene-2,6-diyl group, and in order to further increase the ratio, at least two of A1's are preferably a 1,4-phenylene group or a naphthalene-2,6-diyl group and more preferably a 1,4-phenylene group.
In order to decrease the viscosity, Z1 is preferably —CH2O—, —OCH2—, —CF2O—, —OCF2—, —CF═CF—, —C≡C—, or a single bond, more preferably —CF2O—, —OCF2—, —CH2CH2—, or a single bond, and particularly preferably a single bond, and in order to increase the T→i, Z1 is preferably —C≡C— or a single bond.
In the case of putting importance on viscosity, X1 is preferably a hydrogen atom, and in the case of putting importance on miscibility with other liquid crystal components, X1 is preferably a fluorine atom.
In the case of putting importance on viscosity, m is preferably 1 or 2, and in the case of putting importance on the Tni, m is preferably 3 or 4. In order to increase the miscibility with the liquid crystal composition, m is preferably 2 or 3.
As a compound having high Δn and an excellent balance of viscosity and miscibility with other liquid crystal components, the compound represented by General Formula (1) is preferably a compound represented by General Formula (1-1).
In the formula, R01, R02, A1, Z1, and X1 have the same meaning as R01, R02, A1, Z1, and X1 in General Formula (1), respectively;
Z2 represents —CH2O—, —OCH2—, —CF2O—, —OCF2—, —COO—, —OCO—, —CH2CH2—, —CF2CF2—, —CH═CH—, —CF═CF—, —C≡C—, or a single bond;
X2, X3, and X4 each independently represents a hydrogen atom, a fluorine atom, or a chlorine atom; and
m1 represents 0, 1, 2, or 3, in the case where m1 is 2 or 3 and plural A1's are present, the plural A1's may be the same as or different from each other, and in the case where m1 is 2 or 3 and plural Z1's are present, the plural Z1's may be the same as or different from each other.
Furthermore, the compound represented by General Formula (1-1) is preferably a compound represented by General Formula (1-1A).
In the formula, R01, A1, Z1, X1, X2, X3, X4, and m1 have the same meaning as R1, A1, Z1, X1, X2, X3, X4, and m1 in General Formula (1-1), respectively; and
R03 represents a hydrogen atom or an alkyl group having 1 to 3 carbon atoms, one —CH2— or two or more —CH2— in the alkyl group may be substituted with —O—, —S—, —COO—, —OCO—, or —CO— as long as an oxygen atom is not directly adjacent to another oxygen atom, and at least one hydrogen atom present in the alkyl group may be substituted with a fluorine atom.
R03 more preferably represents a hydrogen atom or a methyl group.
Furthermore, the compounds represented by General Formula (1) or General Formula (1-1) are preferably a compound satisfying at least one of the following matters.
The liquid crystal compound represented by General Formula (1) is preferably compounds represented by the following General Formula (1-1-1) to General Formula (1-1-49), which are the compound represented by General Formula (1-1) (in the formulas, R01, R02, and X1 have the same meaning as R01, R02, and X1 in General Formula (1), respectively). The liquid crystal composition of the present invention preferably contains one or more compounds represented by General Formula (1-1-1) to General Formula (1-1-49), more preferably contains one or more compounds represented by General Formula (1-1-1) to General Formula (1-1-6), General Formula (1-1-9) to General Formula (1-1-14), General Formula (1-1-17) to General Formula (1-1-21), and General Formula (1-1-26) to General Formula (1-1-49), still more preferably contains one or more compounds represented by General Formula (1-1-1) to General Formula (1-1-6), General Formula (1-1-9) to General Formula (1-1-14), and General Formula (1-1-17) to General Formula (1-1-21), and particularly preferably contains one or more compounds represented by General Formula (1-1-9) to General Formula (1-1-12).
In addition, the liquid crystal compound represented by General Formula (1) is preferably compounds represented by the following General Formula (1-2-1) to General Formula (1-2-7) (In the formulas, R01, R02, and X1 represent the same meaning as R01, R02, and X1 in General Formula (1), respectively). The liquid crystal composition of the present invention preferably contains one or more compounds represented by General Formula (1-2-1) to General Formula (1-2-7).
In the liquid crystal composition of the present invention, the compound represented by General Formula (1) is preferably contained in the amount of 0.1% by mass or more as a lower limit in the composition (the following % in the composition represents % by mass), preferably contained in the amount of 0.3% or more, preferably contained in the amount of 0.5% or more, preferably contained in the amount of 0.8% or more, preferably contained in the amount of 1% or more, preferably contained in the amount of 2% or more, preferably contained in the amount of 3% or more, preferably contained in the amount of 5% or more, preferably contained in the amount of 6% or more, preferably contained in the amount of 7% or more, preferably contained in the amount of 8% or more, preferably contained in the amount of 9% or more, preferably contained in the amount of 10% or more, preferably contained in the amount of 13% or more, preferably contained in the amount of 15% or more, preferably contained in the amount of 18% or more, and preferably contained in the amount of 20% or more. In addition, if the content is large, a problem such as precipitation occurs, and accordingly, as an upper limit, the compound represented by General Formula (1) is preferably contained in the amount of 80% or less, preferably contained in the amount of 70% or less, preferably contained in the amount of 60% or less, preferably contained in the amount of 55% or less, preferably contained in the amount of 50% or less, preferably contained in the amount of 45% or less, preferably contained in the amount of 40% or less, preferably contained in the amount of 38% or less, preferably contained in the amount of 35% or less, preferably contained in the amount of 33% or less, preferably contained in the amount of 32% or less, preferably contained in the amount of 30% or less, preferably contained in the amount of 28% or less, preferably contained in the amount of 25% or less, preferably contained in the amount of 23% or less, preferably contained in the amount of 21% or less, preferably contained in the amount of 20% or less, preferably contained in the amount of 18% or less, and preferably contained in the amount of 15% or less. One type of the compound represented by General Formula (1) may be used alone or two or more types of the compound may be used at the same time.
A liquid crystal compound having an allyl ether group at the terminal has satisfactory properties as a constituent component of the liquid crystal composition, but has a problem in reliability. However, by difluorinating a specific position of a benzene ring having an allyl ether group, the compound represented by General Formula (1) improves reliability, further improves compatibility, and decreases viscosity without impairing original excellent properties of the skeleton. Furthermore, by imparting positive dielectric anisotropy, the compound represented by General Formula (1) is an extremely effective compound as a constituent component of the liquid crystal composition having positive dielectric anisotropy.
Since the compound represented by General Formula (1) has a wide nematic temperature range, large refractive index anisotropy, high solubility, and low viscosity, if the compound represented by General Formula (1) is contained in the liquid crystal composition, the liquid crystal composition is obtained, which has high refractive index anisotropy (Δn) and sufficiently low viscosity (η), achieves a wide nematic phase temperature range by suppressing a decrease in a nematic phase-isotropic liquid phase transition temperature (Tni), exhibits high compatibility, and has a high response speed and excellent reliability when the liquid crystal composition is used in a liquid crystal display element. Therefore, in particular, the liquid crystal composition can be appropriately used in a liquid crystal composition for a FFS mode liquid crystal display for mobile phones or cars. In addition, in the case where an alkyl group substituted with a fluorine atom for R2 in General Formula (1) is selected, positive dielectric anisotropy can be imparted, and the compound represented by General Formula (1) can be extremely appropriately used as a component configuring the liquid crystal composition having positive dielectric anisotropy. For example, the compound represented by General Formula (1) exhibits a liquid crystal phase in the range of 40° C. to 110° C. alone, and has Δn of about 0.26, flow viscosity of about 25 mPa·s, which is low, and dielectric anisotropy of about +4, and further has extremely satisfactory compatibility in the case of being used as a component of the liquid crystal composition.
General Formula (2):
R21 is preferably an alkyl group having 1 to 8 carbon atoms, an alkenyl group having 2 to 8 carbon atoms, or an alkoxy group having 1 to 8 carbon atoms, and is preferably linear. In the case where R21 is an alkenyl group, R21 is preferably selected from the group represented by any one of Formula (R1) to Formula (R5).
A black point in each formula represents a point linking to a ring.
A21 is preferably a trans-1,4-cyclohexylene group, a 1,4-phenylene group, a 3-fluoro-1,4-phenylene group, a 3,5-difluoro-1,4-phenylene group, a tetrahydropyran group, or a 1,3-dioxane-2,5-diyl group.
In order to decrease the viscosity, B21 is preferably the following.
In order to increase the T→i, the following group:
is preferable as B21.
X21, X22, X23, X24, and X25 each independently is preferably a hydrogen atom in order to decrease the viscosity and increase the T→i, and is preferably a fluorine atom in order to increase the Δε.
In the case where X21 and X22 are each independently a fluorine atom or hydrogen atom, B21 preferably represents the following group in order to increase the Δε.
In order to decrease the viscosity, the following group:
is preferable as B21.
In the case where X23 to X25 each independently represents a fluorine atom or a hydrogen atom, B21 preferably represents any of the following groups in order to increase the Δε.
In order to decrease the viscosity, the following group:
is preferable as B21.
Y21 and Y22 preferably represent a fluorine atom, —CF3, or —OCF3 to thereby improve lower limit temperature of a nematic phase and better operation at low temperature or storage properties of the liquid crystal composition. In order to increase the Δε, Y21 and Y22 preferably represent a fluorine atom, a cyano group, —CF3, or —OCF3, and in order to decrease the viscosity, Y21 and Y22 preferably represent a fluorine atom. In consideration of stability of the compound, Y21 and Y22 preferably represent a fluorine atom, —CF3, or —OCF3.
B21 is particularly preferably one selected from the following moiety structures.
Z21 is preferably a single bond, —CH═CH—, —C≡C—, —CH2CH2—, —(CH2)4—, —OCH2—, —CH2O—, —OCF2—, or —CF2O—, and more preferably a single bond, —OCH2—, —CH2O—, —OCF2—, or —CF2O—.
m21 preferably represents 2 or 3. In the case where plural A21's and/or Z21's are present, these may be the same as or different from each other.
The compound represented by General Formula (2) preferably contains one or more compounds represented by General Formula (LC2-a).
In the formula, X26 and X27 each independently represents a hydrogen atom or a fluorine atom, Z23 represents —OCH2—, —CH2O—, —OCF2—, or —CF2O—, and R21, A21, Z21, X21, X22, Y21, and m21 have the same meaning as R21, A21, Z21, X21, X22, Y21, and m21 in General Formula (2), respectively.
X26 and X27 are preferably a fluorine atom, either X26 or X27 is preferably a fluorine atom, and both of X26 and X27 are preferably fluorine atoms.
The compound represented by General Formula (LC2-a) preferably contains at least one of the compounds represented by General Formula (LC2-a1) to General Formula (LC2-a12).
In the formulas, R21, X21, X22, X26, X27, and Y21 represent the same meaning as R21, X21, X22, X26, X27, and Y21 in General Formula (2), respectively, and X30, X31, X32 , and X33 each independently represents a hydrogen atom or a fluorine atom.
The compound represented by General Formula (LC2-a) more preferably contains at least one of the compounds represented by (LC2-a4) to (LC2-a6), (LC2-a10), and (LC2-a11).
Furthermore, the compound represented by General Formula (2) preferably contains one or more compounds represented by General Formula (LC2-b).
In the formula, A22 is a group selected from the group consisting of (a) 1,4-cyclohexylene group in which one —CH2— or two or more —CH2— non-adjacent to each other present in this group may be substituted with —O— or —S—, (b) 1,4-phenylene group in which one —CH═ or two or more —CH═ non-adjacent to each other present in this group may be substituted with —N═ and at least one hydrogen atom present in this group may be substituted with a fluorine atom, and (c) naphthalene-2,6-diyl group in which one —CH═ or two or more —CH═ non-adjacent to each other present in this group may be substituted with —N═ and at least one hydrogen atom present in this group may be substituted with a fluorine atom; m23 represents 1 or 2; and R21, A21, X21, X22, and Y21 have the same meaning as R21, A21, X21, X22, and Y21 in General Formula (2), respectively.
The compound represented by General Formula (LC2-b) preferably contains one or more compounds represented by General Formula (LC2-b1) to General Formula (LC2-b21).
In the formulas, X34, X35, X36, X37, X38, X39, X50, and X51 each independently represents a hydrogen atom or a fluorine atom, and R21, X21, X22, and Y21 have the same meaning as R21, X21, X22, and Y21 in General Formula (LC2-b), respectively.
The compound represented by General Formula (LC2-b) more preferably contains one or more compounds represented by General Formula (LC2-b5) to General Formula (LC2-b8), General Formula (LC2-b10) to General Formula (LC2-b12), and General Formula (LC2-b18).
In addition, the compound represented by General Formula (LC2) preferably contains the following compounds other than the compounds of General Formula (LC2-a) and General Formula (LC2-b) and more preferably contains General Formula (LC2-16) and General Formula (LC2-17).
In the formulas, X40, X41, X42, X43, X44, X45, X46, X47, X48, X49, and X50 each independently represents a hydrogen atom or a fluorine atom, and R21, X21, X22, X23 , X24, X25, Y21, and Y22 have the same meaning as R21, X21, X22, X23, X24, X25, Y21, and Y22 in General Formula (2), respectively.
In the liquid crystal composition of the present invention, the compound represented by General Formula (2) is preferably contained, as a lower limit, in the amount of 0.5% or more, preferably contained in the amount of 1% or more, preferably contained in the amount of 2% or more, preferably contained in the amount of 4% or more, preferably contained in the amount of 5% or more, preferably contained in the amount of 8% or more, preferably contained in the amount of 10% or more, and preferably contained in the amount of 15% or more. In addition, the compound represented by General Formula (2) is preferably contained, as an upper limit, in the amount of 80% or less, preferably contained in the amount of 70% or less, preferably contained in the amount of 65% or less, preferably contained in the amount of 60% or less, preferably contained in the amount of 55% or less, preferably contained in the amount of 50% or less, preferably contained in the amount of 45% or less, preferably contained in the amount of 40% or less, preferably contained in the amount of 37% or less, preferably contained in the amount of 35% or less, preferably contained in the amount of 34% or less, preferably contained in the amount of 30% or less, preferably contained in the amount of 28% or less, preferably contained in the amount of 25% or less, and preferably contained in the amount of 20% or less. One type of the compound represented by General Formula (1) may be used alone or two or more types of the compound may be used at the same time.
In General Formula (LC1),
R11 and R12 each independently is preferably an alkyl group having 1 to 8 carbon atoms, an alkenyl group having 2 to 8 carbon atoms, an alkoxy group having 1 to 8 carbon atoms, or an alkenyloxy group having 2 to 8 carbon atoms, and preferably linear. In the case where R11 and R12 represent an alkenyl group, R11 and R12 are preferably selected from the group represented by any one of Formula (R1) to Formula (R5).
A black point in each formula represents a point linking to a ring.
A combination of R11 and R12 is not particularly limited, and a combination in which both represent an alkyl group, a combination in which one of the above represents an alkyl group and the other represents an alkenyl group, or a combination in which one of the above represents an alkyl group and the other represents an alkoxy group is preferable.
A11 to A13 each independently is preferably any one of the following structures.
A11 to A13 each independently is more preferably any one of the following structures.
Z11 and Z12 each independently is preferably a single bond, —CH═CH—, —C≡C—, —CH2CH2—, —(CH2)4—, —OCH2—, —CH2O—, —OCF2—, or —CF2O—, more preferably a single bond, —CH2CH2—, —OCF2—, or —CF2O—, and particularly preferably a single bond.
m11 preferably represents an integer of 1 or 2. In the case where plural A11's and/or Z11's are present, these may be the same as or different from each other.
The compound represented by General Formula (LC1) is more preferably compounds represented by the following General Formula (LC1-1) to General Formula (LC1-39). The liquid crystal composition of the present invention preferably contains one or more compounds represented by (LC1-1) to (LC1-26) as the compound represented by General Formula (LC1), and more preferably contains one or more compounds represented by (LC1-1) to (LC1-5), (LC1-7), (LC1-15), (LC1-16), (LC1-18), and (LC1-38).
In the formulas, R11 and R12 have the same meaning as R11 and R12 in General Formula (LC1), respectively.
The compound represented by General Formula (LC1) is preferably the compounds represented by the above.
Furthermore, the liquid crystal composition still more preferably contains one or more compounds selected from the group consisting of the following compounds in the amount of 70% by mass at most, as the compound represented by General Formula (LC1).
In the formulas, alkyl and alkyl* each independently represents an alkyl group having 1 to 5 carbon atoms or an alkoxy group, and alkenyl and alkenyl* each independently represents an alkenyl group having 2 to 5 carbon atoms or an alkenyloxy group.
In the liquid crystal composition of the present invention, the compound represented by General Formula (LC1) is preferably contained, as a lower limit, in the amount of 1% or more, preferably contained in the amount of 5% or more, preferably contained in the amount of 10% or more, preferably contained in the amount of 13% or more, preferably contained in the amount of 15% or more, preferably contained in the amount of 18% or more, preferably contained in the amount of 20% or more, preferably contained in the amount of 25% or more, preferably contained in the amount of 28% or more, preferably contained in the amount of 30% or more, preferably contained in the amount of 33% or more, preferably contained in the amount of 35% or more, preferably contained in the amount of 38% or more, preferably contained in the amount of 40% or more, preferably contained in the amount of 43% or more, preferably contained in the amount of 45% or more, preferably contained in the amount of 48% or more, preferably contained in the amount of 50% or more, preferably contained in the amount of 53% or more, preferably contained in the amount of 55% or more, preferably contained in the amount of 58% or more, and preferably contained in the amount of 60% or more. In addition, the compound represented by General Formula (LC1) is preferably contained, as an upper limit, in the amount of 99% or less, preferably contained in the amount of 98% or less, preferably contained in the amount of 95% or less, preferably contained in the amount of 93% or less, preferably contained in the amount of 90% or less, preferably contained in the amount of 87% or less, preferably contained in the amount of 85% or less, preferably contained in the amount of 83% or less, preferably contained in the amount of 80% or less, preferably contained in the amount of 88% or less, preferably contained in the amount of 85% or less, preferably contained in the amount of 83% or less, preferably contained in the amount of 80% or less, preferably contained in the amount of 78% or less, preferably contained in the amount of 75% or less, preferably contained in the amount of 73% or less, preferably contained in the amount of 70% or less, preferably contained in the amount of 68% or less, preferably contained in the amount of 65% or less, preferably contained in the amount of 63% or less, and preferably contained in the amount of 60% or less. One type of the compound represented by General Formula (1) may be used alone or two or more types of the compound may be used at the same time.
In the liquid crystal composition of the present invention, the compounds represented by General Formula (1) and General Formula (2) are preferably contained, as a lower limit, in the amount of 1% or more, preferably contained in the amount of 5% or more, preferably contained in the amount of 10% or more, preferably contained in the amount of 13% or more, preferably contained in the amount of 15% or more, preferably contained in the amount of 18% or more, preferably contained in the amount of 20% or more, preferably contained in the amount of 23% or more, preferably contained in the amount of 25% or more, preferably contained in the amount of 30% or more, preferably contained in the amount of 35% or more, preferably contained in the amount of 38% or more, and preferably contained in the amount of 40% or more. In addition, the compounds represented by General Formula (1) and General Formula (2) are preferably contained, as an upper limit, in the amount of 90% or less, preferably contained in the amount of 80% or less, preferably contained in the amount of 75% or less, preferably contained in the amount of 70% or less, preferably contained in the amount of 65% or less, preferably contained in the amount of 60% or less, preferably contained in the amount of 58% or less, preferably contained in the amount of 55% or less, preferably contained in the amount of 53% or less, preferably contained in the amount of 50% or less, preferably contained in the amount of 48% or less, preferably contained in the amount of 46% or less, preferably contained in the amount of 45% or less, preferably contained in the amount of 43% or less, preferably contained in the amount of 40% or less, preferably contained in the amount of 38% or less, preferably contained in the amount of 78% or less, preferably contained in the amount of 75% or less, preferably contained in the amount of 35% or less, preferably contained in the amount of 33% or less, and preferably contained in the amount of 30% or less.
In the liquid crystal composition of the present invention, the compounds represented by General Formula (1) and General Formula (LC1) are preferably contained, as a lower limit, in the amount of 1% or more, preferably contained in the amount of 5% or more, preferably contained in the amount of 10% or more, preferably contained in the amount of 15% or more, preferably contained in the amount of 20% or more, preferably contained in the amount of 25% or more, preferably contained in the amount of 30% or more, preferably contained in the amount of 35% or more, preferably contained in the amount of 38% or more, preferably contained in the amount of 40% or more, preferably contained in the amount of 43% or more, preferably contained in the amount of 45% or more, preferably contained in the amount of 48% or more, preferably contained in the amount of 50% or more, preferably contained in the amount of 53% or more, preferably contained in the amount of 55% or more, preferably contained in the amount of 58% or more, preferably contained in the amount of 60% or more, preferably contained in the amount of 63% or more, preferably contained in the amount of 65% or more, preferably contained in the amount of 68% or more, and preferably contained in the amount of 70% or more. In addition, the compounds represented by General Formula (1) and General Formula (LC1) are preferably contained, as an upper limit, in the amount of 99% or less, preferably contained in the amount of 98% or less, preferably contained in the amount of 96% or less, preferably contained in the amount of 95% or less, preferably contained in the amount of 93% or less, preferably contained in the amount of 90% or less, preferably contained in the amount of 87% or less, preferably contained in the amount of 85% or less, preferably contained in the amount of 83% or less, preferably contained in the amount of 80% or less, preferably contained in the amount of 88% or less, preferably contained in the amount of 85% or less, preferably contained in the amount of 83% or less, preferably contained in the amount of 80% or less, preferably contained in the amount of 78% or less, preferably contained in the amount of 75% or less, preferably contained in the amount of 73% or less, preferably contained in the amount of 70% or less, preferably contained in the amount of 68% or less, preferably contained in the amount of 65% or less, preferably contained in the amount of 63% or less, and preferably contained in the amount of 60% or less.
The liquid crystal composition of the present invention can contain one or more optically active compounds. Any optically active compound can be used as long as the compound can twist and align liquid crystal molecules. Normally, this twist is changed by the temperature and accordingly, a plurality of optically active compounds can be used in order to obtain a desired temperature dependency. In order not to have a bad influence on the temperature range or viscosity of the nematic liquid crystal phase, it is preferable to select and use the optically active compound having a strong twisting effect. As this optically active compound, liquid crystals such as cholesteric nonanoate or compounds represented by the following General Formula (Ch-1) to General Formula (Ch-6) are preferably contained.
In the formulas, Rc1, Rc2, and R* each independently represents an alkyl group having 1 to 15 carbon atoms, one —CH2— or two or more —CH2— in the alkyl group may be substituted with —O—, —CH═CH—, —CO—, —OCO—, —COO—, —C≡C—, —CF2O—, or —OCF2— as long as an oxygen atom is not directly adjacent to another oxygen atom; one or more hydrogen atoms in the alkyl group may be arbitrarily substituted with a halogen atom; however, R* has at least one of a branched chain group having optical activity and a halogen-substituted group; Zc1 and Zc2 each independently represents a single bond, —CH═CH—, —C≡C—, —CH2CH2—, —(CH2)4—, —COO—, —OCO—, —OCH2—, —CH2O—, —OCF2—, or —CF2O—; D1 and D2 represent a cyclohexane ring or a benzene ring; one —CH2— or two or more —CH2— in the cyclohexane ring may be substituted with —O— as long as an oxygen atom is not directly adjacent to another oxygen atom; one —CH2CH2— or two or more —CH2CH2— in the ring may be substituted with —CH═CH—, —CF2O—, or —OCF2—; one —CH═ or two or more —CH═ in the benzene ring may be substituted with —N═ as long as a nitrogen atom is not directly adjacent to another nitrogen atom; one or more hydrogen atoms in the ring may be substituted with F, Cl, or CH3; t1 and t2 represent 0, 1, 2, or 3; and MG*, Qc1, and Qc2 represent the following structures.
In the formula, D3 and D4 represent a cyclohexane ring or a benzene ring, one —CH2— or two or more —CH2— in the cyclohexane ring may be substituted with —O— as long as an oxygen atom is not directly adjacent to another oxygen atom; one —CH2CH2— or two or more —CH2CH2— in the ring may be substituted with —CH═CH—, —CF2O—, or —OCF2—; one —CH═ or two or more —CH═ in the benzene ring may be substituted with —N═ as long as a nitrogen atom is not directly adjacent to another nitrogen atom; and one or more hydrogen atoms in the ring may be substituted with F, Cl, or CH3.
The liquid crystal composition of the present invention may contain one or more polymerizable compounds, and the polymerizable compound is preferably a disk-shape liquid crystal compound having a structure in which a benzene derivative, a triphenylene derivative, a truxene derivative, a phthalocyanine derivative, or a cyclohexane derivative is used as a mother nucleus in the center of molecules and a linear alkyl group, a linear alkoxy group, or a substituted benzoyloxy group is radially substituted as a side chain thereof.
Specifically, the polymerizable compound is preferably a polymerizable compound represented by General Formula (PC).
In the formula, P1 represents a polymerizable functional group; Sp1 represents a spacer group having 0 to 20 carbon atoms; Qp1 represents a single bond, —O—, —NH—, —NHCOO—, —OCONH—, —CH═CH—, —CO—, —COO—, —OCO—, —OCOO—, —OOCO—, —CH═CH—, —CH═CH—COO—, —OCO—CH═CH—, or —C≡C—; p1 and p2 each independently represents 1, 2, or 3; MGp represents a mesogenic group or a mesogenity supporting group; Rp1 represents a halogen atom, a cyano group, or an alkyl group having 1 to 25 carbon atoms; one CH2 group or two or more CH2 groups in the alkyl group may be substituted with —O—, —S—, —NH—, —N(CH3)—, —CO—, —COO—, —OCO—, —OCOO—, —SCO—, —COS—, or —C≡C— as long as an O atom is not directly adjacent to another O atom; or Rp1 may be P2-Sp2-Qp2-; and P2, Sp2, and Qp2 have the same meaning as P1, Sp1, and Qp1, respectively.
MGp of the polymerizable compound represented by General Formula (PC) is more preferably a polymerizable compound represented by the following structure.
In the formula, C01 to C03 each independently represents a 1,4-phenylene group, a 1,4-cyclohexylene group, a 1,4-cyclohexenyl group, a tetrahydropyran-2,5-diyl group, a 1,3-dioxane-2,5-diyl group, a tetrahydrothiopyran-2,5-diyl group, a 1,4-bicyclo(2,2,2)octylene group, a decahydro naphthalene-2,6-diyl group, a pyridine-2,5-diyl group, a pyrimidine-2,5-diyl group, a pyrazine-2,5-diyl group, a 1,2,3,4-tetrahydro naphthalene-2,6-diyl group, a 2,6-naphthylene group, a phenanthrene-2,7-diyl group, a 9,10-dihydrophenanthrene-2,7-diyl group, a 1,2,3,4,4a,9,10a-octahydrophenanthrene 2,7-diyl group, or a fluorene 2,7-diyl group; the 1,4-phenylene group, the 1,2,3,4-tetrahydro naphthalene-2,6-diyl group, the 2,6-naphthylene group, the phenanthrene-2,7-diyl group, the 9,10-dihydrophenanthrene-2,7-diyl group, the 1,2,3,4,4a,9,10a-octahydrophenanthrene 2,7-diyl group, and the fluorene-2,7-diyl group may have, as a substituent, one or more F, Cl, CF3, OCF3, cyano groups, alkyl groups having 1 to 8 carbon atoms, alkoxy groups, alkanoyl groups, alkanoyloxy groups, alkenyl groups having 2 to 8 carbon atoms, alkenyloxy groups, alkenoyl groups, or alkenoyloxy groups; Zp1 and Zp2 each independently represents —COO—, —OCO—, —CH2CH2—, —OCH2—, —CH2O—, —CH═CH—, —C≡C—, —CH═CHCOO—, —OCOCH═CH—, —CH2CH2COO—, —CH2CH2OCO—, —COOCH2CH2—, —OCOCH2CH2—, —CONH—, —NHCO—, or a single bond; and p3 represents 0, 1, or 2.
Here, Sp1 and Sp2 each independently represents an alkylene group, the alkylene group may be substituted with one or more halogen atoms or CN, and one CH2 group or two or more CH2 groups present in this group may be substituted with —O—, —S—, —NH—, —N(CH3)—, —CO—, —COO—, —OCO—, —OCOO—, —SCO—, —COS—, or —C≡C— as long as an O atom is not directly adjacent to another O atom. Also, P1 and P2 each is independently preferably any one of the following general formulas.
In the formulas, Rp2 to Rp6 each independently represents a hydrogen atom, a halogen atom, or an alkyl group having 1 to 5 carbon atoms.
More specifically, the polymerizable compound represented by General Formula (PC) is preferably polymerizable compounds represented by General Formula (PC0-1) to General Formula (PC0-6).
In the formulas, p4 each independently represents 1, 2, or 3.
More specifically, the polymerizable compound represented by General Formula (PC) is preferably polymerizable compounds represented by General Formula (PC1-1) to General Formula (PC1-9).
In the formulas, p5 represents 0, 1, 2, 3, or 4.
Among the above, Sp1, Sp2, Qp1, and Qp2 are preferably a single bond, P1 and P2 are preferably Formula (PC0-a), more preferably an acryloyloxy group and a methacryloyloxy group, p1+p4 is preferably 2, 3, or 4, and Rp1 is preferably H, F, CF3, OCF3, CH3, or OCH3. Furthermore, the polymerizable compound represented by General Formula (PC) is preferably compounds represented by General Formula (PC1-2), General Formula (PC1-3), General Formula (PC1-4), and General Formula (PC1-8).
In addition, MGp in General Formula (PC) is preferably a disk-shape liquid crystal compound represented by General Formula (PC1)-9.
In the formulas, R7 each independently represents P1-Sp1-Qp1 or a substituent of General Formula (PC1-e); R81 and R82 each independently represents a hydrogen atom, a halogen atom, or a methyl group; R83 represents an alkoxy group having 1 to 20 carbon atoms; and at least one hydrogen atom in the alkoxy group may be substituted with substituents represented by General Formula (PC0-a) to (PC0-d).
The use amount of the polymerizable compound is preferably 0.05% to 2.0% by mass.
In the liquid crystal composition containing the polymerizable compound of the present invention, a liquid crystal display element is prepared by polymerizing the polymerizable compound. At this time, it is required to reduce an unpolymerized component to a desired amount or less, and a compound having a biphenyl group and/or a terphenyl group in the moiety structure of General Formula (LC0) is preferably contained in the liquid crystal composition. More specifically, compounds represented by General Formula (LC0-10) to General Formula (LC0-27), General Formula (LC0-48) to General Formula (LC0-53) and General Formula (LC0-60) to General Formula (LC0-68) are preferable, and one or more compounds are selected and preferably contained in the amount of 0.1% to 40% by mass. In addition, a compound in the group consisting of the polymerizable compounds represented by General Formula (PC1-1) to General Formula (PC1-3), General Formula (PC1-8) and General Formula (PC1-9) is preferably used in combination.
Furthermore, the liquid crystal composition can contain one or more antioxidants, and further contain one or more UV absorbing agents. The antioxidant is preferably selected from the compounds represented by following General Formula (E-1) and/or General Formula (E-2).
In the formulas, Re1 represents an alkyl group having 1 to 15 carbon atoms, one —CH2— or two or more —CH2— in the alkyl group may be substituted with —O—, —CH═CH—, —CO—, —OCO—, —COO—, —C≡C—, —CF2O—, or —OCF2— as long as an oxygen atom is not directly adjacent to another oxygen atom, and one or more hydrogen atoms in the alkyl group may be arbitrarily substituted with a halogen atom;
Ze1 and Ze2 each independently represents a single bond, —CH═CH—, —C≡C—, —CH2CH2—, —(CH2)4—, —COO—, —OCO—, —OCH2—, —CH2O—, —OCF2—, or —CF2O—; and
E1 represents a cyclohexane ring or a benzene ring, one —CH2— or two or more —CH2— in the cyclohexane ring may be substituted with —O— as long as an oxygen atom is not directly adjacent to another oxygen atom, one —CH2CH2— or two or more —CH2CH2— in the ring may be substituted with —CH═CH—, —CF2O—, or —OCF2—, one —CH═ or two or more —CH═ in the benzene ring may be substituted with —N═ as long as a nitrogen atom is not directly adjacent to another nitrogen atom, one or more hydrogen atoms in the ring may be substituted with F, Cl, or CH3, and q1 represents 0, 1, 2, or 3.
The liquid crystal composition of the present invention can be used as a liquid crystal display element, in particular, a liquid crystal display element for active matrix driving, for example, for a TN mode, an OCB mode, an ECB mode, an IPS (including FFS electrode) mode, or a VA-IPS mode (including FFS electrode). Here, the VA-IPS mode is a method in which in the absence of applied voltage, a liquid crystal material having positive dielectric anisotropy (Δε>0) is vertically aligned on a substrate surface to drive liquid crystal molecules by pixel electrodes and common electrodes disposed on the same substrate surface, and the method has an advantage in that since the liquid crystal molecules are arrayed in a direction of a curved electric field generated by the pixel electrodes and common electrodes, division of the pixels or formation of a multi-domain is easy and a response is excellent. According to non-patent documents Proc. 13th IDW, 97 (1997), Proc. 13th IDW, 175 (1997), SID Sym.Digest, 319 (1998), SID Sym.Digest, 838 (1998), SID Sym.Digest, 1085 (1998), SID Sym.Digest, 334 (2000), and Eurodisplay Proc., 142 (2009), the method is referred to as various names such as EOC, VA-IPS, or the like, but in the present invention, hereinafter the method is referred to as “VA-IPS”.
In general, a threshold voltage (Vc) of freedericksz transition in the TN and ECB modes is represented by the following equation.
In the IPS mode, the threshold voltage is represented by the following equation.
In the VA mode, the threshold voltage is represented by the following equation.
In the equations, Vc represents freedericksz transition (V), π represents a ratio of the circumference of a circle to its diameter, dcell represents a gap between a first substrate and a second substrate (μm), dgap represents a gap between the pixel electrodes and common electrodes (μm), dITO represents a width of the pixel electrodes and/or common electrodes (μm), <r1>, <r2>, and <r3> represent an extrapolation length (μm), K11 represents an elastic constant (N) of a spray, K22 represents an elastic constant (N) of a twist, K33 represents an elastic constant (N) of a bend, and Δε represents dielectric anisotropy.
Meanwhile, in the VA-IPS mode, the following equation 4 is applied with respect to the present invention and the like.
In the equation, Vc represents freedericksz transition (V), π represents a ratio of the circumference of a circle to its diameter, dcell represents a gap between a first substrate and second substrate (μm), dgap represents a gap between the pixel electrodes and common electrodes (μm), dITO represents a width of the pixel electrodes and/or common electrodes (μm), <r>, <r′>, and <r3> represent an extrapolation length (μm), K33 represents an elastic constant (N) of a bend, and Δε represents dielectric anisotropy.
As a cell configuration from the equation 4, as dgap is smaller and dITO is greater, a low driving voltage is achieved, and as a liquid crystal composition to be used, by selecting the liquid crystal composition having a greater absolute value of Δε and smaller K33, a low driving voltage is achieved.
The liquid crystal display element which is prepared by using the liquid crystal composition of the present invention can be prepared by performing a rubbing treatment while using a polyimide, a polyamide compound or the like, as a method for aligning liquid crystal molecules on a substrate surface. In addition, the liquid crystal display element can be prepared by a photo alignment technology using a chalcone, cinnamate, cinnamoyl compound or the like. Also, as a new alignment method, a method for causing a polymerizable liquid crystal compound to be incorporated into an alignment layer and polymerizing the polymerizable liquid crystal compound can be applied.
The liquid crystal composition of the present invention can be adjusted to exhibit preferable values of Δε, K11, and K33.
The product (Δn·d) of the refractive index anisotropy (Δn) of the liquid crystal composition and the gap (d) between the first substrate and the second substrate of a display device is strongly related to viewing angle characteristics and response speed. Accordingly, the gap (d) tends to be as small as 3 to 4 μm. The product (Δn·d) is particularly preferably 0.31 to 0.33 for the TN, ECB, and IPS (liquid crystal aligns substantially horizontal to the substrate surface in the absence of applied voltage) modes. For the VA-IPS mode, the product is preferably 0.20 to 0.59 and more preferably 0.30 to 0.40 in the case where the alignment is vertical with respect to the both substrates. Since the suitable value of the product (Δn·d) differs depending on the mode of various display elements, a liquid crystal composition which is applied to various modes has the refractive index anisotropy (Δn) in the range of 0.070 to 0.110, in the range of 0.100 to 0.140, or in the range of 0.130 to 0.180. It is possible to prepare liquid crystal compositions each having a refractive index anisotropy (Δn) falling within any of the different ranges.
The liquid crystal composition of the present invention containing the compound represented by General Formula (PC) as a polymerizable compound can provide a polymer-stabilized liquid crystal display element for a TN mode, an OCB mode, an ECB mode, an IPS mode, or a VA-IPS mode, which is prepared by polymerizing the polymerizable compound contained in the liquid crystal composition in the absence or presence of applied voltage. Specifically, the liquid crystal composition containing the polymerizable compound is interposed between two substrates, and the polymerizable compound in the liquid crystal composition is polymerized by energy such as ultraviolet rays in the absence or presence of applied voltage to prepare the liquid crystal display element. In the liquid crystal display element, an alignment state of liquid crystal molecules can be stored by polymerization of the polymerizable compound and accordingly stability of the alignment state can be improved. Also, it is expected that the response speed is improved.
Hereinafter, the present invention will be described in detail using Examples, but the present invention is not limited thereto. Also, hereinafter, “%” in the composition of Examples and Comparative Examples means “% by mass”.
The physical properties of the liquid crystal composition are presented as follows:
TN-I: Nematic phase-isotropic liquid phase transition temperature (° C.)
T-n: Lower limit temperature (° C.) of nematic phase
ε⊥: Dielectric constant in a direction perpendicular to the molecular long axis at 25° C.
Δε: Dielectric anisotropy at 25° C.
no: Refractive index for ordinary rays at 25° C.
Δn: Refractive index anisotropy at 25° C.
Vth: Voltage (V) applied to a 6 μm-thick cell at which the transmittance changes by 10% when square waves are applied at a frequency of 1 KHz at 25° C.
η: Bulk viscosity (mPa·s) at 20° C.
γ1: Rotational viscosity (mPa·s)
K11/pN: Elastic constant (N) of a spray
K22/pN: Elastic constant (N) of a twist
K33/pN: Elastic constant (N) of a bend
Compounds are abbreviated as follows.
In addition, the results of the properties when the liquid crystal composition is stored at −20° C., −25° C., −30° C., and −40° C. are shown in the following tables. The numbers in the tables represent a storage time, “O” means that a state of liquid crystals before storage is maintained after the storage time, and “X” means that precipitation is recognized after the storage time.
The prepared liquid crystal compositions and the physical property values thereof are shown in the following.
The prepared liquid crystal compositions and the physical property values thereof are shown in the following.
The liquid crystal compositions in Comparative Examples were prepared such that the nematic phase-isotropic liquid phase transition temperature (TN-I) and the value of dielectric anisotropy (Δε) at 25° C. were about the same as those in the Examples, respectively. The values of η in Examples 1 to 6 were within the range of 13.7 mPa·s to 14.7 mPa·s, whereas the values of η in Comparative Examples 1 and 2 were 18.4 mPa·s and 18.5 mPa·s, respectively. In addition, the values of γ1 in Examples 1 to 6 were within the range of 68 mPa·s to 79 mPa·s, whereas the values of γ1 in Comparative Examples 1 and 2 were 94 Pa·s and 87 Pa·s, respectively. In addition, in the liquid crystal composition of Example 4 or 5, precipitation was not recognized after the storage of 168 hours at −30° C. and it was confirmed that the composition exhibits satisfactory phase stability even at low temperature. However, in the liquid crystal compositions of Comparative Examples 1 and 2, precipitation occurred after 72 hours at −30° C.
With respect to Comparative Examples 1 and 2, the compositions have a high dielectric anisotropy, which is about +8, the upper limit of the liquid crystal temperature range is high, which is around 100° C., and however, the storage properties at −30° C. is low, and the viscosity (γ1) is from 87 to 94 [mPa·S], which is high. Meanwhile, with respect to Examples 1 to 6, it is understood that while the physical property values in Examples 1 to 6 are comparable to those in Comparative Examples 1 and 2, the viscosity (γ1) is low and the storage properties at low temperature are improved.
The prepared liquid crystal compositions and the physical property values thereof are shown in the following.
The prepared liquid crystal compositions and the physical property values thereof are shown in the following.
The prepared liquid crystal compositions and the physical property values thereof are shown in the following.
The prepared liquid crystal compositions and the physical property values thereof are shown in the following.
The prepared liquid crystal compositions and the physical property values thereof are shown in the following.
The prepared liquid crystal compositions and the physical property values thereof are shown in the following.
The prepared liquid crystal compositions and the physical property values thereof are shown in the following.
The prepared liquid crystal compositions and the physical property values thereof are shown in the following.
The prepared liquid crystal compositions and the physical property values thereof are shown in the following.
The prepared liquid crystal compositions and the physical property values thereof are shown in the following.
The prepared liquid crystal compositions and the physical property values thereof are shown in the following.
The prepared liquid crystal compositions and the physical property values thereof are shown in the following.
The prepared liquid crystal compositions and the physical property values thereof are shown in the following.
The prepared liquid crystal compositions and the physical property values thereof are shown in the following.
The prepared liquid crystal compositions and the physical property values thereof are shown in the following.
The prepared liquid crystal compositions and the physical property values thereof are shown in the following.
The prepared liquid crystal compositions and the physical property values thereof are shown in the following.
The prepared liquid crystal compositions and the physical property values thereof are shown in the following.
The prepared liquid crystal compositions and the physical property values thereof are shown in the following.
Number | Date | Country | Kind |
---|---|---|---|
2014-156267 | Jul 2014 | JP | national |
Filing Document | Filing Date | Country | Kind |
---|---|---|---|
PCT/JP2015/071324 | 7/28/2015 | WO | 00 |
Publishing Document | Publishing Date | Country | Kind |
---|---|---|---|
WO2016/017615 | 2/4/2016 | WO | A |
Number | Name | Date | Kind |
---|---|---|---|
4818431 | Eidenschink et al. | Apr 1989 | A |
5032313 | Goto et al. | Jul 1991 | A |
5324449 | Kurmeier et al. | Jun 1994 | A |
5399292 | Buchecker et al. | Mar 1995 | A |
5487845 | Reiffenrath et al. | Jan 1996 | A |
5730904 | Bartmann et al. | Mar 1998 | A |
5733477 | Kondo et al. | Mar 1998 | A |
5800734 | Buchecker et al. | Sep 1998 | A |
5858270 | Matsui et al. | Jan 1999 | A |
5976407 | Tarumi et al. | Nov 1999 | A |
6051288 | Kondo et al. | Apr 2000 | A |
6200654 | Poetsch et al. | Mar 2001 | B1 |
6207076 | Koga et al. | Mar 2001 | B1 |
6210603 | Kondo et al. | Apr 2001 | B1 |
6254941 | Kondou et al. | Jul 2001 | B1 |
6468607 | Takehara et al. | Oct 2002 | B1 |
6579577 | Kondo et al. | Jun 2003 | B2 |
7001646 | Heckmeier et al. | Feb 2006 | B2 |
7175891 | Heckmeier et al. | Feb 2007 | B2 |
7198827 | Takeuchi et al. | Apr 2007 | B1 |
7250198 | Heckmeier et al. | Jul 2007 | B2 |
7361388 | Kirsch et al. | Apr 2008 | B2 |
7604851 | Heckmeier et al. | Oct 2009 | B2 |
7674507 | Lietzau et al. | Mar 2010 | B2 |
7704566 | Heckmeier et al. | Apr 2010 | B2 |
7767277 | Lietzau et al. | Aug 2010 | B2 |
8168083 | Goebel et al. | May 2012 | B2 |
8916718 | Tojo et al. | Dec 2014 | B2 |
9039929 | Kaneoya et al. | May 2015 | B2 |
9079836 | Tojo et al. | Jul 2015 | B2 |
9181484 | Tojo et al. | Nov 2015 | B2 |
9315727 | Tojo et al. | Apr 2016 | B2 |
9321961 | Kaneoya et al. | Apr 2016 | B2 |
9573923 | Tojo et al. | Feb 2017 | B2 |
9587175 | Kaneoya et al. | Mar 2017 | B2 |
9637466 | Tojo et al. | May 2017 | B2 |
20020166994 | Kondo et al. | Nov 2002 | A1 |
20030197153 | Heckmeier et al. | Oct 2003 | A1 |
20030228426 | Heckmeier et al. | Dec 2003 | A1 |
20030236304 | Jolidon et al. | Dec 2003 | A1 |
20050012073 | Goulding et al. | Jan 2005 | A1 |
20050017216 | Poetsch et al. | Jan 2005 | A1 |
20050092966 | Heckmeier et al. | May 2005 | A1 |
20050161637 | Shinano et al. | Jul 2005 | A1 |
20060061699 | Kirsch et al. | Mar 2006 | A1 |
20060263542 | Kirsch et al. | Nov 2006 | A1 |
20060286308 | Kirsch et al. | Dec 2006 | A1 |
20070001149 | Manabe et al. | Jan 2007 | A1 |
20070051919 | Kondou et al. | Mar 2007 | A1 |
20070134444 | Harding et al. | Jun 2007 | A1 |
20070205396 | Czanta et al. | Sep 2007 | A1 |
20080132716 | Lietzau et al. | Jun 2008 | A1 |
20080199635 | Hirschmann et al. | Aug 2008 | A1 |
20090065739 | Haseba et al. | Mar 2009 | A1 |
20090103011 | Bernatz et al. | Apr 2009 | A1 |
20090230355 | Czanta et al. | Sep 2009 | A1 |
20090302273 | Tanaka | Dec 2009 | A1 |
20100127211 | Tanaka | May 2010 | A1 |
20100294991 | Saito et al. | Nov 2010 | A1 |
20100308267 | Wittek et al. | Dec 2010 | A1 |
20100328600 | Shimada et al. | Dec 2010 | A1 |
20110001090 | Wittek et al. | Jan 2011 | A1 |
20110024682 | Czanta et al. | Feb 2011 | A1 |
20110037024 | Kobayashi | Feb 2011 | A1 |
20110037912 | Saito et al. | Feb 2011 | A1 |
20110193022 | Tanaka et al. | Aug 2011 | A1 |
20110233466 | Jansen et al. | Sep 2011 | A1 |
20110253934 | Lietzau et al. | Oct 2011 | A1 |
20110291048 | Hamano et al. | Dec 2011 | A1 |
20110315924 | Kojima et al. | Dec 2011 | A1 |
20110315925 | Hiraoka et al. | Dec 2011 | A1 |
20130300996 | Takeuchi et al. | Nov 2013 | A1 |
20130306908 | Jansen et al. | Nov 2013 | A1 |
20140034876 | Gotoh et al. | Feb 2014 | A1 |
20140084210 | Yanai et al. | Mar 2014 | A1 |
20140225036 | Kaneoya et al. | Aug 2014 | A1 |
20140275577 | Tojo et al. | Sep 2014 | A1 |
20150087847 | Tojo et al. | Mar 2015 | A1 |
20150124205 | Kaneoya et al. | May 2015 | A1 |
20150159086 | Kaneoya et al. | Jun 2015 | A1 |
20150184076 | Kaneoya et al. | Jul 2015 | A1 |
20150203757 | Kaneoya et al. | Jul 2015 | A1 |
20150218451 | Kaneoya et al. | Aug 2015 | A1 |
20150284634 | Kaneoya et al. | Oct 2015 | A1 |
20150322343 | Kaneoya et al. | Nov 2015 | A1 |
20160186059 | Kaneoya et al. | Jun 2016 | A1 |
20170198219 | Taniguchi | Jul 2017 | A1 |
Number | Date | Country |
---|---|---|
1184462 | Jun 1998 | CN |
102186821 | Sep 2011 | CN |
102643653 | Aug 2012 | CN |
41 32 006 | Apr 1993 | DE |
4416256 | Nov 1994 | DE |
10 2009 009 631 | Sep 2009 | DE |
102010015824 | Mar 2011 | DE |
112013004132 | Nov 2016 | DE |
0 156 554 | Oct 1985 | EP |
0 882 696 | Dec 1998 | EP |
H02-501311 | May 1990 | JP |
H02-233626 | Sep 1990 | JP |
2-289529 | Nov 1990 | JP |
H04-501575 | Mar 1992 | JP |
H06-504032 | May 1994 | JP |
6-239776 | Aug 1994 | JP |
H8-283183 | Oct 1996 | JP |
9-157202 | Jun 1997 | JP |
10-67988 | Mar 1998 | JP |
H10-101599 | Apr 1998 | JP |
H10130187 | May 1998 | JP |
10-204016 | Aug 1998 | JP |
11-29771 | Feb 1999 | JP |
2000-169413 | Jun 2000 | JP |
2000-355560 | Dec 2000 | JP |
2001-011458 | Jan 2001 | JP |
2001-019649 | Jan 2001 | JP |
2001-026560 | Jan 2001 | JP |
3122199 | Jan 2001 | JP |
2003-176251 | Jun 2003 | JP |
2003-183656 | Jul 2003 | JP |
2003-261873 | Sep 2003 | JP |
2003-286217 | Oct 2003 | JP |
2003-533557 | Nov 2003 | JP |
2004-529214 | Sep 2004 | JP |
2004-352721 | Dec 2004 | JP |
2004-355560 | Dec 2004 | JP |
2005-154724 | Jun 2005 | JP |
2005-517079 | Jun 2005 | JP |
2005-220355 | Aug 2005 | JP |
2005-232214 | Sep 2005 | JP |
2005-232215 | Sep 2005 | JP |
2005-232455 | Sep 2005 | JP |
2005-529176 | Sep 2005 | JP |
2005250223 | Sep 2005 | JP |
2006-515283 | May 2006 | JP |
2006-257274 | Sep 2006 | JP |
2006-328400 | Dec 2006 | JP |
2007-501301 | Jan 2007 | JP |
2007-23071 | Feb 2007 | JP |
2007-503405 | Feb 2007 | JP |
2007-503485 | Feb 2007 | JP |
2007-503487 | Feb 2007 | JP |
2007-51291 | Mar 2007 | JP |
2007-070295 | Mar 2007 | JP |
2007-177241 | Jul 2007 | JP |
2007-526931 | Sep 2007 | JP |
2007-277127 | Oct 2007 | JP |
2008-69153 | Mar 2008 | JP |
2008-189927 | Aug 2008 | JP |
2008-222588 | Sep 2008 | JP |
2008-545669 | Dec 2008 | JP |
2009-067780 | Apr 2009 | JP |
2009-84560 | Apr 2009 | JP |
2009-179813 | Aug 2009 | JP |
2009-185285 | Aug 2009 | JP |
2009-215556 | Sep 2009 | JP |
2009-292730 | Dec 2009 | JP |
2010-500980 | Jan 2010 | JP |
2010-275390 | Dec 2010 | JP |
2011-037998 | Feb 2011 | JP |
2011-516628 | May 2011 | JP |
2011-136998 | Jul 2011 | JP |
2011-148761 | Aug 2011 | JP |
2011-168530 | Sep 2011 | JP |
2011-195587 | Oct 2011 | JP |
2012-117062 | Jun 2012 | JP |
5263461 | May 2013 | JP |
2013-170246 | Sep 2013 | JP |
5382268 | Jan 2014 | JP |
2014-40413 | Mar 2014 | JP |
5435318 | Mar 2014 | JP |
2014-62212 | Apr 2014 | JP |
2014-105178 | Jun 2014 | JP |
20060119879 | Nov 2006 | KR |
9611897 | Apr 1996 | WO |
9632365 | Oct 1996 | WO |
9737960 | Oct 1997 | WO |
9823564 | Jun 1998 | WO |
2004058676 | Jul 2004 | WO |
2005019377 | Mar 2005 | WO |
2008105286 | Sep 2008 | WO |
2009034867 | Mar 2009 | WO |
2009125668 | Oct 2009 | WO |
2009150963 | Dec 2009 | WO |
2010047260 | Apr 2010 | WO |
2012043387 | Apr 2012 | WO |
2012100809 | Aug 2012 | WO |
2012161178 | Nov 2012 | WO |
2013018796 | Feb 2013 | WO |
2013099754 | Jul 2013 | WO |
2013141116 | Sep 2013 | WO |
2013172162 | Nov 2013 | WO |
14030481 | Feb 2014 | WO |
2015029876 | Mar 2015 | WO |
Entry |
---|
International Search Report dated Oct. 20, 2015, issued in counterpart International Application No. PCT/JP2015/071324 (2 pages). |
International Search Report dated Sep. 29, 2015, issued in counterpart International Application No. PCT/JP2015/071323 (3 pages). |
Decision to Grant a Patent dated Feb. 26, 2016, issued in counterpart Japanese Patent Application No. 2015-560121, w/English translation. |
Non Final Office Action dated Oct. 19, 2017, issued in U.S. Appl. No. 15/320,974. |
Non Final Office Action dated Jun. 19, 2017, issued in US. Appl. No. 15/320,974. |
International Search Report dated Nov. 18, 2014, issued in counterpart Application No. PCT/JP2014/071903. |
Non Final Office Action dated Feb. 9, 2018, issued in U.S. Appl. No. 14/912,262. |
International Search Report dated Oct. 7, 2014, issued in counterpart Application No. PCT/JP2014/068784. |
Non Final Office Action dated Aug. 12, 2016, issued in U.S. Appl. No. 14/904,226. |
Notice of Allowance dated Jan. 17, 2017, issued in U.S. Appl. No. 14/904,226. |
International Search Report dated Oct. 7, 2014, issued in counterpart Application No. PCT/JP2014/072633. |
Non Final Office Action dated Jul. 6, 2016, issued in U.S. Appl. No. 14/907,034. |
Notice of Allowance dated Oct. 12, 2016, issued in U.S. Appl. No. 14/907,034. |
Kuchar, Miroslav, et al., “Use of QSAR in Design of Antiinflammatory Fluorinated Arylalkanoic Acids”, Collection of Czechoslovak Chemical Communications, 1990, vol. 55, No. 1, pp. 296-306. |
Resistry(stn) [Online], Oct. 3, 2011 (Oct. 3, 2011), (retrieval date: Mar. 11, 2013 (Mar. 11, 2013)) CAS resistration No. 1334226-61-7. |
Number | Date | Country | |
---|---|---|---|
20170218269 A1 | Aug 2017 | US |